VIRS
Pacer BioThreat Strategy ETF
VIRS
VIRS
Delisted
VIRS was delisted on the 10th of October, 2024.
4 hedge funds and large institutions have $1.12M invested in Pacer BioThreat Strategy ETF in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$195K |
2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$79.2K |
Top Sellers
1 |
UBS Group
Zurich,
Switzerland
|
-$135K |
2 |
Rockefeller Capital Management
New York
|
-$39K |
3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$25.3K |
4 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
-$28 |